Overstimulation of the NMDA receptors by glutamate is implicated in neurodegenerative disorders, including Alzheimer’s disease (AD) 1

The NMDA receptor antagonist memantine is approved for the treatment of moderate/severe AD alone or in combination with cholinesterase inhibitors2-4

Memantine has been shown to reduce clinical deterioration in moderate/severe AD1

Furthermore, treatment with memantine has been shown to reduce symptoms such as agitation, aggression, irritability,and appetite disturbances5

Acess our Slide Deck on treatment principles of AD and learn more about pharmacological treatment of AD.

file_download Download in HQ

Related content

image Image
Parkinson’s Disease and Braak stages

The Braak staging scheme is a valuable model for conceptualizing PD progression and categorizes PD into stages of neuropathological changes.

11.04.2024 Parkinson’s Disease
Unmet Medical Needs in Bipolar Disorder and The Role of Clinicians in Addressing Them play_circle Video play_circle
Unmet Medical Needs in Bipolar Disorder and The Role of Clinicians in Addressing Them

Professor Christoph Correll discusses the complexities of bipolar disorder, shedding light on the real-world challenges in treatment, the critical role of clinicians, and the necessity of patient-centric approaches in psychiatry.

06.03.2024 Mental Health
The Heterogeneity of Bipolar Disorder: From Clinical Observations to Precision Psychiatry play_circle Video play_circle
The Heterogeneity of Bipolar Disorder: From Clinical Observations to Precision Psychiatry

Bipolar disorder is a chronic and highly debilitating mental disorder characterized by recurrent mood episodes. A major challenge is its heterogeneous clinical presentation with diverse comorbidities and symptomatology.

06.03.2024 Mental Health